After a video was released by Project Veritas showing a Pfizer executive bragging about the company’s investigation of mutating Covid variants to profit from future mRNA “vaccines,” Congressional members have expressed serious concerns. The video has been viewed over 30 million times on Twitter and has prompted inquiries to the heads of the Health and Human Services, National Institute of Health, and the Food and Drug Administration regarding their plans for addressing the evidence of corporate wrongdoing at Pfizer.
The letter was signed by multiple senators and house members, including Sen. Mike Lee (R-UT), Sen. Ron Johnson (R-WI), Sen. Ted Cruz (R-TX), Rep. Mary Miller (R-IL), Rep. Chip Roy (R-TX), Rep. Bob Good (R-VA), Rep. Andy Biggs (R-AZ), Rep. Bill Posey (R-FL), Rep. Greg Steube (R-FL), and Rep. Lauren Boebert (R-CO).
The video features Dr. Jordon Triston Walker, who works at Pfizer as the Director of Research and Development, Strategic Operations – mRNA Scientific Planner. In the video, Dr. Walker made two concerning statements. The first statement was regarding Pfizer’s exploration of “directed evolution” research, which aims to enhance the efficacy of its COVID-19 vaccine. This type of research, also known as gain-of-function (GOF) research, involves strengthening viruses to allow for the study of their effects and the development of countermeasures. The National Institutes of Health (NIH) placed a moratorium on funding for GOF research from 2014 to 2017 following safety protocol breaches at the NIH and CDC.
The second assertion made by Dr. Walker in the video was that there exists a “revolving door” relationship between the FDA and major pharmaceutical companies. This means that regulatory officials may be compromising current safety standards in exchange for potential employment opportunities in the future. Such regulatory capture is unjust to smaller companies that lack the ability to influence agency decisions and can also restrict patient access to novel treatments.
The letter from Congress posed inquiries to the FDA and NIH regarding Pfizer’s potential use of gain-of-function or directed evolution research in the development of its COMIRNATY® (COVID-19 Vaccine, mRNA). In addition, the letter sought to learn what measures have been implemented to ensure that all FDA officials treat companies impartially, regardless of their size or market influence, and to prevent regulatory capture and conflicts of interest among agency personnel.
The release of the video has sparked serious concerns among Congress members and the public alike, and it remains to be seen what action will be taken in response to the evidence of corporate malfeasance at Pfizer corp.
The preceding article is a summary of an article that originally appeared on Trending Politics